Stress, Allostatic Load, Catecholamines, and Other Neurotransmitters in Neurodegenerative Diseases

被引:0
|
作者
David S. Goldstein
机构
[1] National Institutes of Health,Clinical Neurocardiology Section, National Institute of Neurological Disorders and Stroke
来源
Cellular and Molecular Neurobiology | 2012年 / 32卷
关键词
Stress; Allostasis; Catecholamines; Homeostasis; Parkinson disease;
D O I
暂无
中图分类号
学科分类号
摘要
As populations age, the prevalence of geriatric neurodegenerative diseases will increase. These diseases generally are multifactorial, arising from complex interactions among genes, environment, concurrent morbidities, treatments, and time. This essay provides a concept for the pathogenesis of Lewy body diseases such as Parkinson disease, by considering them in the context of allostasis and allostatic load. Allostasis reflects active, adaptive processes that maintain apparent steady states, via multiple, interacting effectors regulated by homeostatic comparators—“homeostats.” Stress can be defined as a condition or state in which a sensed discrepancy between afferent information and a setpoint for response leads to activation of effectors, reducing the discrepancy. “Allostatic load” refers to the consequences of sustained or repeated activation of mediators of allostasis. From the analogy of an idling car, the revolutions per minute of the engine can be maintained at any of a variety of levels (allostatic states). Just as allostatic load (cumulative wear and tear) reflects design and manufacturing variations, byproducts of combustion, and time, eventually leading to engine breakdown, allostatic load in catecholaminergic neurons might eventually lead to Lewy body diseases. Central to the argument is that catecholaminergic neurons leak vesicular contents into the cytoplasm continuously during life and that catecholamines in the neuronal cytoplasm are autotoxic. These neurons therefore depend on vesicular sequestration to limit autotoxicity of cytosolic transmitter. Parkinson disease might be a disease of the elderly because of allostatic load, which depends on genetic predispositions, environmental exposures, repeated stress-related catecholamine release, and time.
引用
收藏
页码:661 / 666
页数:5
相关论文
共 50 条
  • [21] Oxidative Stress in Neurodegenerative Diseases
    Niedzielska, Ewa
    Smaga, Irena
    Gawlik, Maciej
    Moniczewski, Andrzej
    Stankowicz, Piotr
    Pera, Joanna
    Filip, Magorzata
    MOLECULAR NEUROBIOLOGY, 2016, 53 (06) : 4094 - 4125
  • [22] Oxidative stress in neurodegenerative diseases
    Chen, Xueping
    Guo, Chunyan
    Kong, Jiming
    NEURAL REGENERATION RESEARCH, 2012, 7 (05) : 376 - 385
  • [23] Oxidative stress in neurodegenerative diseases
    Aslan, M
    Özben, T
    FRONTIERS IN NEURODEGENERATIVE DISORDERS AND AGING: FUNDAMENTAL ASPECTS, CLINICAL PERSPECTIVES AND NEW INSIGHTS, 2004, 358 : 158 - 169
  • [24] Oxidative stress in neurodegenerative diseases
    Xueping Chen1
    Neural Regeneration Research, 2012, 7 (05) : 376 - 385
  • [25] Oxidative Stress in Neurodegenerative Diseases
    Domanskyi, Andrii
    Parlato, Rosanna
    ANTIOXIDANTS, 2022, 11 (03)
  • [26] Oxidative Stress in Neurodegenerative Diseases
    Ewa Niedzielska
    Irena Smaga
    Maciej Gawlik
    Andrzej Moniczewski
    Piotr Stankowicz
    Joanna Pera
    Małgorzata Filip
    Molecular Neurobiology, 2016, 53 : 4094 - 4125
  • [27] Oxidative stress in neurodegenerative diseases
    Simonian, NA
    Coyle, JT
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1996, 36 : 83 - 106
  • [28] Neurodegenerative diseases and oxidative stress
    Emerit, J
    Edeas, A
    Bricaire, F
    BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (01) : 39 - 46
  • [29] ER stress and neurodegenerative diseases
    Lindholm, D
    Wootz, H
    Korhonen, L
    CELL DEATH AND DIFFERENTIATION, 2006, 13 (03): : 385 - 392
  • [30] Neurodegenerative diseases and oxidative stress
    Barnham, KJ
    Masters, CL
    Bush, AI
    NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (03) : 205 - 214